CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

398 hedge funds and large institutions have $2.54B invested in CRISPR Therapeutics in 2024 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 112 increasing their positions, 120 reducing their positions, and 69 closing their positions.

Holders
398
Holders Change
-12
Holders Change %
-2.93%
% of All Funds
5.3%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
65
Increased
112
Reduced
120
Closed
69
Calls
$81.6M
Puts
$91.6M
Net Calls
-$9.97M
Net Calls Change
+$24.9M

Top Buyers

1
OAG
1
Orbis Allan Gray
Bermuda
$58.1M
2
AIM
2
ARK Investment Management
Florida
$353M
3
UBS Group
3
UBS Group
Switzerland
$78.1M
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$150M
5
Capital International Investors
5
Capital International Investors
California
$344M

Top Sellers

1
BG
1
Bellevue Group
Switzerland
$0
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$0
3
State Street
3
State Street
Massachusetts
$98.1M
4
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$0
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$108M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$353M 8,973,064 +1,474,439 +20%
Capital International Investors
2
Capital International Investors
California
$344M 8,743,523 +816,789 +10%
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$150M 3,811,708 +1,074,238 +39%
BlackRock
4
BlackRock
New York
$109M 2,759,326 -35,973 -1%
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$108M 2,745,676 -222,358 -7%
NAMA
6
Nikko Asset Management Americas
New York
$108M 2,745,676 -221,543 -7%
State Street
7
State Street
Massachusetts
$98.1M 2,491,525 -501,463 -17%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$87.5M 2,223,293 -152,873 -6%
UBS Group
9
UBS Group
Switzerland
$78.1M 1,983,990 +1,310,402 +195%
Vanguard Group
10
Vanguard Group
Pennsylvania
$68.3M 1,735,998 +10,579 +0.6%
NMC
11
NEA Management Company
Maryland
$62.5M 1,587,854 – –
OAG
12
Orbis Allan Gray
Bermuda
$58.1M 1,476,119 +1,476,119 New
EC
13
EcoR1 Capital
California
$54.7M 1,389,276 – –
BBA
14
Baker Bros. Advisors
New York
$51.5M 1,308,011 +464,936 +55%
Bank of America
15
Bank of America
North Carolina
$47.7M 1,211,509 +129,746 +12%
SOCM
16
SR One Capital Management
Pennsylvania
$41.3M 1,048,951 – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$39.4M 1,000,868 -7,346 -0.7%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$37.3M 947,301 +122,695 +15%
Loomis, Sayles & Company
19
Loomis, Sayles & Company
Massachusetts
$35.9M 910,965 -34,302 -4%
Balyasny Asset Management
20
Balyasny Asset Management
Illinois
$35.2M 893,935 +270,285 +43%
Citadel Advisors
21
Citadel Advisors
Florida
$34.6M 878,896 +360,349 +69%
Charles Schwab
22
Charles Schwab
California
$28.5M 723,032 -1,209 -0.2%
UBS AM
23
UBS AM
Illinois
$27.2M 690,191 +13,865 +2%
VVM
24
Versant Venture Management
California
$19.6M 498,558 – –
Morgan Stanley
25
Morgan Stanley
New York
$19.5M 495,002 -137,001 -22%
1
2 3 4 5